-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, K6IbgVrdrg8JeLxlwre75LwYhZnaR+3DY2RI+HibsCGLodVFN/Cg8LeFJOEQ9ghG mFBURNGVFMNO+32OugkZVw== 0001170918-06-000241.txt : 20060320 0001170918-06-000241.hdr.sgml : 20060320 20060320164959 ACCESSION NUMBER: 0001170918-06-000241 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20060320 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20060320 DATE AS OF CHANGE: 20060320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA INNOTECH CORP CENTRAL INDEX KEY: 0000830736 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 581729436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14257 FILM NUMBER: 06699098 BUSINESS ADDRESS: STREET 1: 2401 MERCED ST. CITY: SAN LEANDRO STATE: CA ZIP: 94577 BUSINESS PHONE: 5104839620 MAIL ADDRESS: STREET 1: 2401 MERCED ST. CITY: SAN LEANDRO STATE: CA ZIP: 94577 FORMER COMPANY: FORMER CONFORMED NAME: XTRANA INC DATE OF NAME CHANGE: 20010702 FORMER COMPANY: FORMER CONFORMED NAME: BIOPOOL INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CYTRX BIOPOOL LTD DATE OF NAME CHANGE: 19890716 8-K 1 fm8k-032006.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): MARCH 20, 2006 ALPHA INNOTECH CORP. (Exact name of registrant as specified in its charter) DELAWARE 1-14257 58-1729436 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 2401 MERCED STREET, SAN LEANDRO, CALIFORNIA 94577 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (510) 483-9620 N/A - -------------------------------------------------------------------------------- (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (SEE General Instruction A.2. below): |_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |_| Pre-commencement communications pursuant to Rule 13e-4(c)) under the Exchange Act (17 CFR 240.13e-4c)) ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On March 20, 2006, Alpha Innotech Corp. (the "Company") issued a press release announcing its earnings for the fiscal quarter ended December 31, 2005, the text of which is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K, including the exhibit, is furnished pursuant to Item 2.02 and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities under that Section. Furthermore, the information in the Current Report on Form 8-K, including the exhibit, shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended. ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS (c) EXHIBITS 99.1 Press Release dated March 20, 2006 announcing earnings for the fiscal quarter ended December 31, 2005 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALPHA INNOTECH CORP. Date: March 20, 2006 By: /S/ RONALD BISSINGER -------------------------------------- Ronald Bissinger Chief Financial Officer 3 EXHIBIT INDEX 99.1 Press Release dated March 20, 2006 announcing earnings for the fiscal quarter ended December 31, 2005 4 EX-99 2 ex99-1e.txt EX-99.1 EXHIBIT 99.1 ALPHA INNOTECH REPORTS 23% REVENUE GROWTH IN FOURTH QUARTER OF 2005 March 20, 2006 - Alpha Innotech Corporation, San Leandro, California Alpha Innotech Corp. (OTCBB:APNO), a leading provider of bioanalytical systems for drug discovery and life science research, today reported financial results for the fourth quarter and year ending December 31, 2005. Fourth quarter revenues of $3.892 million increased over 23% from $3.153 million reported in the same period in 2004. The net loss of $84,000 in the fourth quarter ending December 31, 2005 is a 94% reduction from the $1.307 million loss reported in the comparable period of 2004. Revenues for the year ending December 31, 2005 were $12.051 million, a 15% increase from the $10.511 million reported for the same period in 2004. The net loss for the year ending December 31, 2005 was reduced 22% to $3.126 million from the $4.002 million loss reported for 2004. "I am pleased with our strong fourth quarter revenue growth," stated Haseeb Chaudhry, Chief Executive Officer of Alpha Innotech. "We look forward to continuing to build momentum in 2006." William F. Snider, Chairman of Alpha Innotech, stated in a letter to shareholders posted on the company's website today, "As we report 23% revenue growth for the fourth quarter of 2005, I can honestly say that I have never been more excited about the company's prospects." More details of Alpha Innotech's strategy and Mr. Snider's letter to shareholders can be found at the Company's website www.alphainnotech.com. About Alpha Innotech Corporation Founded in 1992 and with over 7,000 systems sold worldwide, Alpha Innotech is a leading developer, manufacturer and marketer of digital imaging and analysis systems for the life science research and drug discovery markets. Our goal is to combine instruments, reagents and bioinformatics software to offer integrated modular technology platforms for functional genomics, proteomics and cell analysis markets. Our customers include pharmaceutical and biotechnology companies as well as universities, medical centers, government research institutes and agencies worldwide. Cautionary Note Regarding Forward-Looking Statements This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those sections. These forward-looking statements involve a number of risks and uncertainties that include, but are not limited to, the Company's need for additional financing, the timing of the introduction and success of new products, and the Company's growth prospects, that could cause actual results to differ materially from those anticipated or planned by these forward-looking statements. Please also refer to the risk factors described in our filings with the Securities and Exchange Commission, including our recent Form 8-K and Form 10-QSB filed with the Securities and Exchange Commission. We assume no obligation to update the forward-looking information contained in this news release. CONTACT: ALPHA INNOTECH CORP. RON BISSINGER, COO/CFO TEL: 510-483-9620 Alpha Innotech Corporation Condensed Consolidated Balance Sheets (in thousands) (unaudited) December 31, -------------------- 2005 2004 ------ ------ ASSETS Current assets: Cash and cash equivalents ................... $ 546 40 Accounts receivable, net .................... 2,411 1,976 Inventory, net .............................. 952 725 Prepaid expenses and other current assets ........................... 212 169 ------ ------ Total current assets ........................ 4,121 2,910 Property and equipment, net ........................ 1,171 1,434 Other assets ....................................... 76 80 ------ ------ Total assets ................................ $5,368 4,424 ====== ====== LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Accounts payable ............................ 1,497 1,617 Accrued liabilities ......................... 1,084 1,089 Current portion of debt ..................... 1,556 1,610 Deferred revenue ............................ 775 575 Other liabilities ........................... 230 181 ------ ------ Total current liabilities ................... 5,142 5,072 Debt, net of current portion ....................... 800 -- ------ ------ Total stockholders' deficit ........................ (574) (648) ------ ------ Total liabilities and stockholders' deficit .................................. $5,368 $4,424 ====== ====== Alpha Innotech Corporation Condensed Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited)
Three Months Ended Twelve Months Ended December 31, December 31, -------------------------- -------------------------- 2005 2004 2005 2004 ----------- ----------- ----------- ----------- Revenue ............................................... $ 3,892 $ 3,153 $ 12,051 $ 10,511 Cost of goods sold .................................... 1,920 1,519 6,410 5,378 ----------- ----------- ----------- ----------- Gross profit .......................................... 1,972 1,634 5,641 5,133 ----------- ----------- ----------- ----------- Operating expenses: Sales and marketing ............................ 1,170 1,076 4,733 3,925 Research and development ....................... 408 436 1,573 1,963 General and administrative ..................... 427 934 1,537 1,968 ----------- ----------- ----------- ----------- Total operating expenses .............................. 2,005 2,446 7,843 7,856 ----------- ----------- ----------- ----------- Loss from operations .................................. (33) (812) (2,202) (2,723) Interest expense ...................................... (65) (321) (307) (574) Other income (expense), net ........................... 14 2 14 (1) ----------- ----------- ----------- ----------- Net loss .............................................. (84) (1,131) (2,495) (3,298) Accretions on redeemable convertible preferred stock .. -- (176) (631) (704) ----------- ----------- ----------- ----------- Net loss applicable to common stockholders ......... $ (84) $ (1,307) $ (3,126) $ (4,002) =========== =========== =========== =========== Loss per common share - basic and diluted ............. $ (0.01) $ (0.49) $ (0.80) $ (1.51) =========== =========== =========== =========== Weighted average shares outstanding - basic and diluted 7,738,433 2,648,980 3,888,451 2,648,473 =========== =========== =========== ===========
# # # -----END PRIVACY-ENHANCED MESSAGE-----